Table 1.
Demographic and clinical measures for ADHD persistence group, remission group, and healthy control group.
| Items | ADHD Persistence n=25 |
Remission n=22 |
Control n=25 |
F/χ2 | p |
|---|---|---|---|---|---|
| Sex | M 20; F 5 | M 19; F 3 | M 19; F 6 | 0.83 | 0.703 |
| Age (years, mean ± SD) | 18.38 ± 0.50 | 18.76 ± 1.10 | 19.60 ± 1.22 | 9.99 | <0.001 |
| IQ (mean ± SD) | 110 ± 8.679 | 113 ± 2 | 115 ± 7.918 | 1.79 | 0.174 |
| Childhood ADHD type | 16 I, 9 C | 16 I, 6 C | n/a | ||
| Adult ADHD type | 17 I, 3 H, 5 C | n/a | n/a | ||
| Current ADHD symptoms (mean ± SD) | |||||
| Inattentive | 6.80 ± 1.71 | 2.00 ± 1.11 | 1.001.04 | 134.51 | <0.001 |
| Hyperactivity-impulsive | 4.00 ± 2.57 | 1.09 ± 1.11 | 0.40 ± 0.65 | 32.18 | <0.001 |
| Total | 10.80 ± 2.71 | 3.09 ± 1.82 | 1.40 ± 1.23 | 152.15 | <0.001 |
| Comorbidities | 7 MDD, 1 OCD, 1 Social phobia, 3 Substance abuse | 2 Dysthymia | n/a |
IQ, estimated full IQ of WAISRC; ADHD, attention-deficit/hyperactivity disorder; MDD, major depression disorder; OCD, obsessive-compulsive disorder; I, inattentive subtype; H, hyperactive-impulsive subtype; C, combined subtype; χ2, chi-square test.